We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.99%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.31B
AUM Growth
-$186M
(-3.4%)
Cap. Flow
-$183M
Cap. Flow
% of AUM
-3.46%
Top 10 Holdings %
Top 10 Hldgs %
19.09%
Holding
839
New
96
Increased
271
Reduced
217
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$58.6M |
| 2 |
Biogen
BIIB
|
+$40.7M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$29.8M |
| 4 |
Baidu
BIDU
|
+$27.4M |
| 5 |
Apple
AAPL
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$62.3M |
| 2 |
Melco Resorts & Entertainment
MLCO
|
+$50M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$31.8M |
| 4 |
Manhattan Associates
MANH
|
+$27.4M |
| 5 |
Copa Holdings
CPA
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.94% |
| 2 | Industrials | 14.89% |
| 3 | Financials | 13.29% |
| 4 | Energy | 11.49% |
| 5 | Consumer Discretionary | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
ASML
ASML
$675B
| $4.8M | 0.09% |
48,551
+18,377
| +61% | +$1.73M |
|
|
TYG
127
Tortoise Energy Infrastructure Corp
TYG
$1.14B
| $4.74M | 0.09% |
24,643
-584
| -2% | -$112K |
|
128
HCA Healthcare
HCA
$84.8B
| $4.74M | 0.09% |
+67,180
| New | +$4.44M |
|
|
WES
129
DELISTED
Western Gas Partners Lp
WES
| $4.52M | 0.09% |
60,314
+937
| +2% | +$70.9K |
|
130
CME Group
CME
$92.2B
| $4.43M | 0.08% |
55,430
+732
| +1% | +$55.2K |
|
131
Costco
COST
$415B
| $4.41M | 0.08% |
35,158
-247
| -0.7% | -$29.9K |
|
132
Lazard
LAZ
$4.37B
| $4.34M | 0.08% |
85,681
-1,709
| -2% | -$89.6K |
|
133
Chevron
CVX
$388B
| $4.27M | 0.08% |
35,816
+1,983
| +6% | +$253K |
|
134
Itaú Unibanco
ITUB
$91.3B
| $4.18M | 0.08% |
751,445
+13,108
| +2% | +$83.5K |
|
135
Mercado Libre
MELI
$91.3B
| $4.17M | 0.08% |
38,414
-750
| -2% | -$78K |
|
136
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $4.16M | 0.08% |
21,095
-1,508
| -7% | -$298K |
|
137
DuPont de Nemours
DD
$18.6B
| $4.14M | 0.08% |
31,187
+18,673
| +149% | +$2.49M |
|
|
NVO
138
Novo Nordisk
NVO
$216B
| $4.14M | 0.08% |
173,836
+57,488
| +49% | +$1.32M |
|
139
Televisa
TV
$1.45B
| $4.14M | 0.08% |
122,130
+29,345
| +32% | +$1.04M |
|
140
Aemetis
AMTX
$119M
| $4.13M | 0.08% |
476,333
+53,677
| +13% | +$528K |
|
141
SPDR Gold Trust
GLD
$131B
| $4.11M | 0.08% |
35,335
-6,315
| -15% | -$779K |
|
142
Illinois Tool Works
ITW
$81.4B
| $4.1M | 0.08% |
48,536
-736
| -1% | -$63.7K |
|
143
lululemon athletica
LULU
$13B
| $4.03M | 0.08% |
95,888
-7,491
| -7% | -$302K |
|
144
Abbott
ABT
$180B
| $4M | 0.08% |
96,268
-1,529
| -2% | -$64.7K |
|
|
MWIV
145
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| $3.97M | 0.07% |
26,770
-4,597
| -15% | -$661K |
|
146
AT&T
T
$165B
| $3.93M | 0.07% |
147,821
+5,651
| +4% | +$150K |
|
147
RTX Corp
RTX
$287B
| $3.84M | 0.07% |
57,722
+4,641
| +9% | +$318K |
|
148
Brookfield Infrastructure Partners
BIP
$18.8B
| $3.78M | 0.07% |
250,649
+24,721
| +11% | +$400K |
|
|
DD
149
DELISTED
Du Pont De Nemours E I
DD
| $3.73M | 0.07% |
54,807
-690
| -1% | -$43.5K |
|
150
ConocoPhillips
COP
$147B
| $3.61M | 0.07% |
47,211
+1,098
| +2% | +$89.8K |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q3 2014 Portfolio in Review
As of Q3 2014, Geneva Advisors held 839 positions worth $5.31B, down 3.4% from $5.49B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geneva Advisors withdrew a net $183M in Q3 2014, closing 105 positions and reducing 217 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $24.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.
Against the trend, Geneva Advisors opened a new position in Discovery, Inc. Series C Common Stock worth $27.5M.
- Geneva Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 736,897 shares worth $27.5M.
- Geneva Advisors added most to AbbVie in Q3 2014, an estimated $58.6M increase.
- Geneva Advisors's biggest Q3 2014 reduction was Warner Bros, cutting an estimated $62.3M.
- Geneva Advisors fully exited ASPEN TECHNOLOGY INC in Q3 2014, selling an estimated $24.6M.
- Geneva Advisors's ten largest holdings make up 19% of its $5.31B portfolio in Q3 2014.
- Geneva Advisors opened 96 new positions and closed 105 in Q3 2014.
- Geneva Advisors's portfolio value fell 3.4% quarter-over-quarter to $5.31B.
Based on Geneva Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.